Verrica Pharmaceuticals buy Needham & Company LLC
Start price
23.08.23
/
50%
€3.90
Target price
23.08.24
€9.25
Performance (%)
-38.46%
End price
24.08.24
€2.40
Summary
This prediction ended on 24.08.24 with a price of €2.40. Massive losses of -38.46% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.62
15.08.24
15.08.24
€10.95
15.08.25
15.08.25
-77.18%
16.08.25
16.08.25
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€9.90
14.05.24
14.05.24
€14.81
14.05.25
14.05.25
-95.10%
15.05.25
15.05.25
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.74
10.11.23
10.11.23
€7.49
10.11.24
10.11.24
-71.24%
11.11.24
11.11.24